Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Metadata
Title
The fellow eye effect of unilateral intravitreal conbercept injections in eyes with diabetic macular edema
Publication date
01-08-2020
Keywords
Edema
Bevacizumab
Published in
Acta Diabetologica / Issue 8/2020
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-020-01511-x

Other articles of this Issue 8/2020

Acta Diabetologica 8/2020 Go to the issue

Review Article

Profile of non-responder and late responder patients treated for diabetic macular edema: systemic and ocular factors

Letter to the Editor

Insulin allergy brought out 8 years after starting insulin therapy in a subject with type 1 diabetes mellitus

Perspectives

Lois Jovanovič: a giant in the field of diabetes and pregnancy

Original Article

Functional correlation between choroidal and retinal vascularity in low-grade diabetic retinopathy

Original Article

Genomic ancestry as a risk factor for diabetic retinopathy in patients with type 1 diabetes from an admixed population: a nested case–control study in Brazil

Original Article

Darbepoetin-α increases the blood volume flow in transplanted pancreatic islets in mice

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits